Difference between revisions of "Team:UCopenhagen/Description"

Line 24: Line 24:
  
 
#top-image img {
 
#top-image img {
 +
width: 100%;
 +
height: auto;
 
  max-width: 100%;
 
  max-width: 100%;
 
  height: auto;
 
  height: auto;
Line 57: Line 59:
  
 
   <div id="top-image">
 
   <div id="top-image">
   <img src="https://static.igem.org/mediawiki/2020/f/f9/T--UCopenhagen--Temporary_Group_Photo_PlaceHolder.jpg">
+
   <img src="https://static.igem.org/mediawiki/2020/d/df/T--UCopenhagen--placeholder-12-6.png">
 
   </div>
 
   </div>
  

Revision as of 19:43, 29 July 2020


Project description
& inspiration

Defining the problem

Generally, people who suffer from CID’s need to monitor their conditions closely. This may include regular hospital visits to measure levels of inflammation and monitor the disease progression. These visits are not only time consuming but exhausting to the patients mentally. Vast research have been conducted, linking hospitalization and depression in patients (REF). Even short visits to your hospital for routine blood samples or check-ups can have a negative impact on mental well-being. Not only does the visits remind patients of the fact that they are ‘sick’, but the time spent on transport and testing is a live-long burden to the individual.
Monitoring the disease is crucial for treatment, yet still 1 out of 3 patients with CID’s receives non-effective treatment (REF). CID’s can behave extremely different from patient to patient, so individual adjustment of treatments is needed, however data on treatment variations are not available for all patient groups?? Thus continuous monitoring of inflammation levels specific for the individual can provide immense benefit for the patient in periods of treatment adjustments or disease relapse.
Current methods for disease tracking are almost exclusively invasive and includes blood-sampling and on occasion more comprehensive procedures such as endoscopies. Invasive methods of testing not only expensive and requiring well trained personal, but they are also unpleasant and could in worst case lead to complications for the patients. In addition they do not allow the patient to self-monitor, hence the need for extensive hospital visits. Conclusively, suffering from a chronic inflammatory disease can be extremely exhausting both physically and mentally. Although much research is being conducted in regards to the treatment of all types of inflammatory diseases, not many monitoring devices exists to make it easier for the individual living with a CID. In order to improve the quality of life for patients worldwide, we have created CIDosis.

Our Solution

With CIDosis, we provide a non-invasive device, allowing CID patients to monitor their own inflammation status. CIDosis aims to improve the quality of life for patients who suffer from chronic inflammatory diseases by providing a patch that will detect levels of inflammatory markers in their sweat. This patch can be placed under the armpit of the patient where it will be continuously collecting sweat during the day, resulting in a color output translating the inflammatory status. Our self-monitoring patch, CIDosis, is an easy-to-use, non-invasive device suitable for home use, and will decrease the need for frequent hospital visits, thereby making life easier for the patients. It allows for transparency for the patient regarding their disease progression and is a tool that can help them discover the best self-management strategy for their disease. Not only can it alleviate the burden of hospital visits, but it can provide valuable information on the therapeutic efficacy of certain drugs, allowing for faster treatment adjustments and continuous dosage regulations as the disease progresses. We envision the use of this patch as a future self-monitoring system for patients suffering from inflammatory diseases worldwide. With the CIDosis patch they have access to a cheap, non-invasive method to measure their daily inflammation in an easy way and track their condition. The utility of such a device is extensive and can alleviate the struggles of many patient groups from Crohn’s disease to Arthritis.

Scientific approach

We are engineering the yeast Saccharomyces cerevisiae to sense presence of inflammation biomarkers (interleukins/cytokines) in human sweat. The yeast is located inside a sweat patch specifically designed for this purpose. Our SPY (Sweat Patch with Yeast) device is placed on the skin, where it continually collects sweat from the patient. The yeast expresses a colored pigment to reflect the level of a certain interleukin of choice. The vision is a modular design, allowing for easy swap of the interleukin receptor in the yeast, so the patch can be tailored to the need of the individual patient group. The yeast is powered by designed receptors that boast very high sensitivity and selectivity, coupled with an efficient pheromone pathway for signal amplification. The SPY can be photographed with a specialized app to analyze the exact level of coloration regardless of light conditions.

The detailed step of the scientific development includes:

Interleukin receptor modification Human interleukin receptors are cloned into yeast, via a fusion between the extracellular receptor domain and an endogenous yeast transmembrane protein. Successful ligand-receptor binding is tested via a common split-ubiquitin signal assay.

Hijacking the yeast pheromone pathway The interleukin signal is amplified for more precise measurement by hijacking the signal amplification steps of the pheromone pathway in yeast. Endogenous G-alpha proteins are modified to induce the pathway upon ligand-receptor binding.

Signal transduction via color expression The signal pathway will, post amplification, induce the transcription of a colorful pigment that will then be expressed in the yeast cell, resulting in a clear, visual color change of the yeast colony.

★ ALERT!

This page is used by the judges to evaluate your team for the medal criterion or award listed below.

Delete this box in order to be evaluated for this medal criterion and/or award. See more information at Instructions for Pages for awards.

Project Description

Bronze Medal Criterion #3

Describe how and why you chose your iGEM project.

Please see the 2020 Medals Page for more information.

What should this page contain?

  • A clear and concise description of your project.
  • A detailed explanation of why your team chose to work on this particular project.
  • References and sources to document your research.
  • Use illustrations and other visual resources to explain your project.

Inspiration

See how other teams have described and presented their projects:

Advice on writing your Project Description

We encourage you to put up a lot of information and content on your wiki, but we also encourage you to include summaries as much as possible. If you think of the sections in your project description as the sections in a publication, you should try to be concise, accurate, and unambiguous in your achievements. Your Project Description should include more information than your project abstract.

References

iGEM teams are encouraged to record references you use during the course of your research. They should be posted somewhere on your wiki so that judges and other visitors can see how you thought about your project and what works inspired you.

About us

We are 9 undergrad and grad students representing University

of Denmark. With out project CIDOSIS, we aim to improve

the lifes of people with Chronic Inflammatory Diseases

Address

University of Copenhagen

Thorvaldsensvej 40, Frederiksberg C

Denmark